欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DK/H/2511/001
药品名称Bortezomib Actavis
活性成分
    • BORTEZOMIB 2.5 mg/ml
剂型Solution for injection
上市许可持有人Actavis Group PTC ehf. Reykjavíkurvegi 76-78 220 Hafnarfjörður Iceland
参考成员国 - 产品名称Denmark (DK)
Bortezomib Actavis
互认成员国 - 产品名称
    • Austria (AT)
    • Belgium (BE)
    • Czechia (CZ)
      Bortezomib Actavis 2,5 mg/ml Injekční roztok
    • Germany (DE)
      Bortezomib Actavis
    • Estonia (EE)
    • Greece (GR)
      BORTEZOMIB/ACTAVIS
    • Spain (ES)
    • Finland (FI)
    • France (FR)
    • Ireland (IE)
    • Hungary (HU)
    • Iceland (IS)
    • Italy (IT)
    • Lithuania (LT)
      Bortezomib Actavis 2,5 mg/ml injekcinis tirpalas
    • Luxembourg (LU)
    • Latvia (LV)
    • Netherlands (NL)
      Bortezomib Actavis 2,5 mg/ml, oplossing voor injectie
    • Norway (NO)
    • Poland (PL)
    • Portugal (PT)
    • Romania (RO)
    • Sweden (SE)
    • Slovenia (SI)
      Bortezomib Actavis 2,5 mg/ml raztopina za injiciranje
    • United Kingdom (GB)
许可日期2016/04/25
最近更新日期2020/07/09
药物ATC编码
    • L01XX32 bortezomib
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Withdrawn（注：已撤市）
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase